CClinicalTrials.gg
CompletedNCT05974748Updated Sep 7, 2023

Role of Propolis Endodontic Irrigant on Post-Operative Pain

A Phase 3 interventional study of Sodium hypochlorite 5.25% and Propolis 20% in Post-operative Pain and Symptomatic Irreversible Pulpitis, sponsored by Dow University of Health Sciences. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-07.

Sponsored by Dow University of Health Sciences · Phase 3, Interventional, and Prevention

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Apr 2023, registered Jul 2023).
Phase
Phase 3
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare propolis and sodium hypochlorite as endodontic irrigants in patients presenting with symptomatic irreversible pulpitis.

. The main question it aims to answer is:

  • if there is any analgesic effects of 20% Propolis compared with 5.25% NaOCl on the intensity of post-operative pain in patients with symptomatic irreversible pulpitis using VAS pain score. Participants will undergo root canal treatment of their teeth using either 20% propolis solution or 5.25% NaOCl in their first visit of a multi-visit root canal treatment.

Researchers will compare 20% Propolis and 5.25% NaOCl to see reduction in Intensity of Post-Operative Pain using visual analogue scale over 72 hour duration.

Read the detailed description

Sodium hypochlorite as an endodontic irrigant, poses problems of toxicity. Additionally, its unfavorable odor, taste, failure to remove the smear layer, and proteolytic effect have deleterious effects on the dentine, creating unfavorable structural and mechanical alterations . To get beyond NaOCl limits and adverse effects, it is necessary to look for a biocompatible, equally effective, and dentine friendly irrigant with greater patient acceptance in taste and odor.

The literature lacks an in-vivo study that investigates the anti-inflammatory with analgesic characteristics of Propolis on post-endodontic pain as an irrigant, in patients with symptomatic irreversible pulpitis. This research will endeavor to fill this gap in literature.

02

Conditions studied

  • Post-operative Pain
  • Symptomatic Irreversible Pulpitis

Keywords

  • Propolis
  • Endodontic Irrigant
03

In context

Pulpitis

302 studies on the registry are indexed under Pulpitis; 67 are open to participants now.

This study's enrollment of 44 is below the median of 62 across 275 interventional studies indexed under Pulpitis.

Browse Pulpitis studies →

Lead sponsor

Dow University of Health Sciences is the lead sponsor of 170 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. ASA-I and II individuals who are between the ages of 18 and 60 years.
  2. Patients with mandibular and maxillary premolars who have been diagnosed with symptomatic irreversible pulpitis (with either a normal periapex or symptomatic apical periodontitis).
  3. Patients who score moderate to severe (4-10) on a preoperative visual analogue scale (VAS=1-10)

Exclusion criteria

Exclusion Criteria:

  1. Patients suffering from severe pain because of traumatic occlusion.
  2. Teeth with extensive damage, calcified canals, periapical radiolucency, root resorption, and an open apex.
  3. Patients with compromised medical condition (ASA-III and above)
  4. Patients who are unable to communicate effectively in either Urdu or English.
  5. Pregnant and lactating ladies
  6. Patients who are allergic to honey or bee pollen.
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
44 participants (actual)

Study arms

  • Active comparator
    Sodium Hypochlorite

    5.25% sodium hypochlorite is the gold standard endodontic irrigant. Other Name: NaOCl

    Drug: Sodium hypochlorite 5.25%

  • Experimental
    Propolis

    Hydroalcoholic 20% propolis will be used as an endodontic irrigant. Other Name: Bee glue

    Drug: Propolis 20%

Interventions

  • DrugSodium hypochlorite 5.25%

    The participants will be randomly divided into two groups using the sealed envelope method during the instrumentation process. The clinician will use the irrigation in accordance with the protocol. Between each instrument in group A, 3 ml of 5.25% sodium hypochlorite (NaOCl) will be used to irrigate each canal.

    Also known as: NaOCl

  • DrugPropolis 20%

    In group B, a 20% hydroalcoholic propolis solution of 3 milliliters will be used to irrigate each canal, between each instrument.

    Also known as: Bee glue

06

What researchers measure

Primary outcomes

  1. Change in post-operative pain intensity on visual analogue scale(0-10)

    Self recorded by patient and then assessed by an intern on a visual analogue scale of 0-10 with 0 being no pain , 10 being worst pain

    Time frame: 24 hours, 48 hours and 72 hours

Secondary outcomes

  1. Need of rescue medicine in both groups

    Self recorded by patient and then assessed by an intern on a visual analogue scale of 0-10 with 0 being no pain , 10 being worst pain

    Time frame: within first 24 hours

07

Study locations

1 site
  • Dow International Dental College
    Karachi, Sindh 75500, Pakistan
08

References and documents

Individual participant data

Plan to share: No — Only investigators and co-investigators of this study will be able to access to participants' personal data. Ownership of the data will remain with the principal investigator and Department of Operative Dentistry, Dow International Dental College(DIDC) , Dow University of Health Sciences

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05974748
Lead sponsor
Dow University of Health Sciences
Responsible party
Tayyaba Tahira (Lecturer, Dow University of Health Sciences) — Principal investigator
First posted
Aug 3, 2023
Start date
Apr 1, 2023
Primary completion
Aug 15, 2023
Completion
Aug 15, 2023
Last update
Sep 7, 2023

Study contacts

Tayyaba Tahira, BDS FCPS
principal investigator · Dow International Dental College, Dow University of Health Sciences
Farah Naz, BDS FCPS
study director · Dow International Dental College, Dow University of Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion